WILLIAM NEWBY: Open Payments
NPI 1417371642 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 8 payments from 7 companies in 2025. Trend: 2023 $315 · 2024 $548 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $39 |
| Foundation Fusion Solutions, LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| BIOTRONIK NRO, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Atland Pharmaceuticals, LLC | 1 | $15 |
Products named: WaveWriter Alpha Prime 16, RELISTOR, XTAMPZA, HORIZANT, General - Pain Management, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE.
Industry payments across GA — which companies pay providers there.
